| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Oklahoma Medical Research Foundation, Cancer Research Program, Oklahoma City, Oklahoma 73104
A continuous human breast tumor cell line (BOT-2) was derived from an infiltrating duct carcinoma. The tumor cell line was grown as a monolayer in flasks, but the cells could be readily adapted to growth in roller cultures. These studies indicate that BOT-2 cells have a 16- to 18-hr doubling time and a modal chromosomal number of 63. The original BOT-2 cell culture has been in continuous cultivation for almost 2 years and has been passed 137 times. The BOT-2 cell line has been differentiated from HeLa cells by isoenzyme studies and chromosomal analysis.
1 Supported in part by USPHS GRS Grant 5-SO1-RR05538.
Received 10/17/74. Accepted 8/ 1/75.
This article has been cited by other articles:
![]() |
R. Nordquist, J. Anglin, and M. Lerner Antibody-induced antigen redistribution and shedding from human breast cancer cells Science, July 22, 1977; 197(4301): 366 - 367. [Abstract] [PDF] |
||||
![]() |
W. Nelson-Rees and R. Flandermeyer Inter- and intraspecies contamination of human breast tumor cell lines HBC and BrCa5 and other cell cultures Science, March 25, 1977; 195(4284): 1343 - 1344. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |